AbbVie Inc. vs Carson Cumberbatch
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- AbbVie Inc. is the larger company by market value: $514.0 B against $410 M for Carson Cumberbatch, 1254 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Nov 20, 2026 for Carson Cumberbatch).
Market value, the same start = 100
From Oct 2026: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | AbbVie Inc. ABBV · #26 in the world | Carson Cumberbatch CARS · #13,416 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇱🇰 Sri Lanka |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | — |
| Founded | 2013 | — |
| Size | ||
| Market cap | $514.0 B | $410 M |
| Revenue | $61.2 B | — |
| Net income | $4.2 B | — |
| Employees | 57,000 | — |
| Valuation | ||
| P/E ratio | 49.7× | — |
| Price to sales | 7.8× | — |
| Free cash flow yield | 3.5% | — |
| Profitability | ||
| Gross margin | 70.2% | — |
| Operating margin | 24.6% | — |
| Net margin | 6.9% | — |
| Return on invested capital | 16.0% | — |
| Growth | ||
| Revenue growth | 8.6% | — |
| Revenue growth, 3 years a year | 1.8% | — |
| Earnings per share growth | -1.3% | — |
| Financial strength | ||
| Interest cover | 5.2× | — |
| Cash | ||
| Free cash flow margin | 29.1% | — |
| Shareholder returns | ||
| Dividend yield | 2.3% | — |
| Shareholder yield | 2.5% | — |
| Strength scores | ||
| Piotroski F-score | 8 of 9 | — |
| Altman Z-score zone | grey | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Nov 2026 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, AbbVie Inc. or Carson Cumberbatch?
AbbVie Inc. is the larger company by market value: $514.0 B against $410 M for Carson Cumberbatch, 1254 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Nov 20, 2026 for Carson Cumberbatch).
More about AbbVie Inc.
More about Carson Cumberbatch
Sources#
Every figure on this page comes from these, with the date shown next to it.